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Diffusion weighted MRIAbstract Background: Evaluation of a clinically N0 neck is essential in cases of head and neck
squamous cell carcinoma (HNSCC) in order to determine whether the neck needs treatment or not.
Purpose: The study was designed to compare the efﬁcacy of DW-MRI with that of PET/CT
scans in the preoperative evaluation of clinically N0 neck in cases of HNSCC.
Methods: A systematic search was performed by the PubMed/MEDLINE to identify and select
the relevant studies published within the last 20 years (up to 20/01/2014). Reported sensitivities,
speciﬁcities, Positive Likelihood Ratio, Negative Likelihood Ratio and Diagnostic Odds Ratio were
metaanalyzed. QUADAS criteria were used to evaluate the methodologic quality of the studies.
Results: Six studies met the inclusion criteria and were analyzed. Only one study evaluated DW-
MRI whereas 5 studies evaluated PET/CT comprising a total sample size of 329 patients. Sensitivity
was homogeneous across studies (P= 0.202), whereas speciﬁcity was heterogeneous across studies
(P= 0.050). The overall sensitivity, speciﬁcity and accuracy rates of DW-MRI in evaluation of a
clinically N0 neck were 100%, 71% and 85% respectively whereas PET/CT scans’ overall sensitiv-
ity, speciﬁcity and accuracy were 68%, 84% and 78% respectively.
Conclusions: The available evidence suggests that DWI is more sensitive than PET/CT in the
preoperative evaluation of cN0 neck in patients with HNSCC. PET/CT exam has low sensitivity
and a positive test would not help the clinician in the management of the patient with clinically
N0 disease and therefore, it should not be routinely used in neck nodal status work-ups.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Ear, Nose, Throat and
Allied Sciences.1. Introduction
Lymphatic metastasis is an important prognostic factor in
patients with HNSCC. Regardless of the primary tumor site,
the presence of a single metastatic lymph node in HNSCC
reduces the 5-year survival rate by approximately 50%. The
presence of bilateral metastatic lymph nodes in the neck
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out nodal metastasis. Cervical lymph node metastases inﬂu-
ence not only the risk of local recurrence but also the risk of
distant metastases, making lymph node status one of the most
important predictors of prognosis. Therefore, accurate assess-
ment of the lymph node status is important for the choice of
treatment.1
Cervical lymph node metastasis staged by palpation has
been demonstrated to be inaccurate; the rate of occult cervical
nodal metastases is at least 30% by simple palpation.2 To
avoid the unnecessary treatment of histologically negative
necks, a staging technique must be sensitive enough to reduce
the risk of occult metastases to less than 20%, which means a
negative predictive value (NPV) of more than 80%.3 With the
development of modern imaging modalities, the American
Joint Committee on Cancer has stated that clinical staging
should include physical examination as well as the results of
other imaging modalities. Research is now directed toward
ﬁnding a staging method sensitive enough to bring the risk
of occult metastases below 20%.
Previous meta-analyses compared the diagnostic accuracy
of different imaging modalities in neck node evaluation. How-
ever, these studies looked at a mixture of cN+ and cN0
patients, and paucity of studies has focused only on patients
with cN0 necks.
The aim of this study is to do a systematic review for the per-
formance of DWI versus PET/CT in the evaluation of neck
lymph node metastasis in clinically N0 neck of patients with
HNSCC.2. Methods
2.1. Search for relevant studies
Using MEDLINE database (www.pubmed.com), we con-
ducted a systematic literature search to identify relevant stud-
ies published within the last 20 years (from 1995 up to 20/1/
2014), which evaluated the role of PET/CT and DWI/MRI
(in combination or separately) in diagnosis of cN0 neck in
patients with HNSCC. Disease-speciﬁc search terms (cN0
neck, clinically negative neck, HNSCC, head and neck squa-
mous cell carcinoma) were combined with diagnostic modality
speciﬁc search terms (PET/CT, Positron emission tomography
and computed tomography, DWI, Diffusion weighted MRI) in
all our searches. The electronic searches were supplemented by
scanning the reference lists from retrieved articles to identify
additional studies that may have been missed during the initial
search. It was decided to include only those studies which are
published in the English language or translated to the English
language; dealing with human subjects, including radiological
procedures (PET/CT and or DWI/MRI) which are used in
cN0 neck of patients with HNSCC. Also patients in the
included studies did not receive any treatment before being
evaluated by imaging techniques and histo-pathological study
should be done to conﬁrm the results of radiological imaging.
In studies that included patients with different diseases, only
those patients with HNSCC with cN0 were included. Excluded
articles: are those articles which miss one or more of the above
mentioned inclusion criteria, duplicated studies or those out-
dated by subsequent ones. Studies that provided insufﬁcient
data to construct a 2 · 2 contingency table were also excluded.2.2. Study selection and data abstraction
From each relevant article, we abstracted the following infor-
mation: type of the study (prospective, retrospective systematic
review, meta-analysis or randomized control), number of cN0
neck of patients with HNSCC (population of the study), nat-
ure of the intervention (PET–CT scan and or DWI and
histopathological examination of neck specimen), outcome
and results (true +ve, false +ve, true ve and false
ve cases).
To calculate sensitivity and speciﬁcity, true-positive (TP)
was considered when PET/CT and/or DWI suggested the loca-
tion of the metastatic cervical lymph node and was subse-
quently conﬁrmed by histopathology, whereas false-positive
(FP) was considered when this location was not conﬁrmed.
When PET/CT and/or DWI did not suggest the location of
the metastatic cervical lymph node and was subsequently con-
ﬁrmed by histopathology, it was considered to be true-negative
(TN). It was considered false-negative (FN) if the metastatic
cervical lymph node was conﬁrmed subsequently to negative
PET/CT and DWI.
2.3. Quality assessment of primary studies
For each included study, the methodological quality was
assessed by using the Quality Assessment of Studies of Diag-
nostic Accuracy Included in Systematic Reviews (QUADAS)
criteria, which is a 14-item instrument.4 The questions in this
checklist are aimed at establishing the validity of the study
under review – that is, making sure that it has been carried
out carefully, and that the conclusions represent an unbiased
assessment of the accuracy and reliability of the test being eval-
uated. Each question covers an aspect of methodology that is
thought to make a difference to the reliability of a study.
If the quality item is achieved, we give it (+), and () for
the quality item not achieved or data not available. Fulﬁllment
of the methodological quality criteria for the included articles
was considered high, acceptable, or low, when the percentage
of the mean (sum/total) of adherence for all included articles
was >70%, 50–70%, or <50%, respectively.5
2.4. Statistical methods
The primary outcome for analysis is the diagnostic perfor-
mance of DWI and PET/CT that detected the neck lymph
node metastasis compared with the reference standard of neck
dissection specimens. Sensitivity and speciﬁcity values were
reported for individual studies. Pooled sensitivities and speci-
ﬁcities of DWI and PET/CT in neck lymph node metastasis
of cN0 neck from individual studies were calculated using a
random effect model.6 The random effect model incorporated
the heterogeneity of the studies into the analysis of the overall
efﬁcacy. Likelihood ratios are metrics that are calculated using
a combination of sensitivity and speciﬁcity values. The Positive
Likelihood Ratio (LR+) is deﬁned as the ratio of sensitivity
(1 speciﬁcity), whereas the Negative Likelihood Ratio
(LR) is deﬁned as the ratio of speciﬁcity (1 sensitivity).
When a diagnostic test has absolutely no discriminating abil-
ity, both likelihood ratios equal 1. Metaanalysis of the col-
lected data was conducted using the software: Meta-Discª
version 1.4.7
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3.1. Study identiﬁcation and eligibility
Our search identiﬁed 1122 potentially relevant studies in
MEDLINE (Table 1). Out of them, there were 406 potentially
eligible studies. We excluded 217 out of the 406 studies because
they miss one or more of the above mentioned inclusion crite-
ria or were duplicated or were outdated by other more recent
ones. Thus, 189 studies remained for possible inclusion and
were retrieved in full text version. After reviewing the full arti-
cle, 183 studies were excluded for the following reasons: some
of them were essay studies while others were containing non
cN0 neck or the primary was non HNSCC. Still other studies
were containing neither DWI nor PET/CT or the pathological
conﬁrmation was not obtained in all cases or a 2 · 2 table
could not be constructed. This process left 6 original articles
which fulﬁlled all inclusion criteria and thus were included
and used for further analyses.
3.2. Methodological quality assessment of the included studies
Systematic review of the included studies using QUADAS
tool4 revealed the following results (Table 2).Table 1 Detailed literature search.
Keywords
DWI versus PET/CT in HNSCC
DWI versus PET/CT
Diﬀusion weighted MRI versus positron emission tomography
and computed tomography
DWI in clinically negative neck
DWI in cN0 neck
DWI in HNSCC
DWI in head and neck squamous cell carcinoma
Diﬀusion weighted mri in cN0 neck
Diﬀusion weighted mri in clinically negative neck
Diﬀusion weighted mri in head and neck squamous cell
carcinoma
Diﬀusion weighted mri in head and neck squamous cell
carcinoma (as a title)
Diﬀusion weighted mri in HNSCC
Diﬀusion weighted imaging in head and neck squamous cell
carcinoma
Diﬀusion weighted imaging in clinically negative neck
Diﬀusion weighted imaging in cN0 neck
Diﬀusion weighted imaging in HNSCC
PET/CT in clinically negative neck
PET/CT in cN0 neck
PET/CT in HNSCC
PET/CT in head and neck squamous cell carcinoma
Positron emission tomograghy and computed tomography in
cN0 neck
Positron emission tomograghy and computed tomography in
clinically negative neck
Positron emission tomography and computed tomography in
HNSCC
Positron emission tomography and computed tomography in
head and neck squamous cell carcinoma
Positron emission tomography and computed tomography in
head and neck squamous cell carcinoma. (as a title)
TotalThe total methodological quality score, expressed as a frac-
tion of the maximum score, ranged from 9/14 (64%) to 13/14
(93%) with mean (82%) (High).
3.3. Analysis of included articles
Our searching of the Medline database revealed no studies
comparing the role of DWI versus PET/CT in evaluation
of cN0 neck in patients with HNSCC. So we divided our
6 included articles into two groups according to whether
DWI or PET–CT scan was used alone for evaluation of
cN0 neck in patients with HNSCC with the histopathologic
analysis of the neck dissection specimen as the gold
standard.
Group (A):
In this group, the patients underwent DWI. This group
includes 13 cN0 neck sides which represent the population
of only one study. The detection rate (true positive) for
DWI was 6 (46%) out of 13 neck sides, false-positive
results were 2(15.5%) out of 13 neck sides, false- negative
results were zero (zero%) out of 13 neck sides and the
true negative results were 5(38.5%) out of 13 neck sides
(Table 3).Number of articles
and their abstracts
Potentially
eligible studies
0 0
5 1
14 2
0 0
0 0
10 7
18 7
1 1
1 1
67 26
5 5
30 11
54 26
1 1
1 1
26 12
16 12
3 3
60 33
195 98
6 4
44 7
97 36
460 108
8 4
1122 406
Table 2 QUADAS tool for methodological quality assessment of included studies.
No. Study Quality items Quality score
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Ratio Percentage (%)
1 Dirix et al.8 + + +  + + + + +   + + + 11/14 79
2 Cetin et al.9 + + + + + + + + +   + + + 12/14 86
3 Chauhan et al.10 + + + + + + + + + +   + + 12/14 86
4 Nahmias et al.11 + + + + + + + + + +  + + + 13/14 93
5 Ozer et al.12 + + +   + +  +   + + + 9/14 64
6 Schoder et al.13 + + +  + + + + + +  + + + 12/14 86
NB: (+) = the quality item achieved while () = the quality item not achieved or data not available.
Table 3 Reported detection rate for DWI in Group A.
No. Study Neck sides DWI
TP FP FN TN
1 Dirix et al.8 13 6 2 0 5
No. = numbers of the study, TP = true positive, FP = false
positive FN= false negative, TN= true negative.
Table 4 Reported detection rate for PET/CT in Group B.
No. Study Neck sides PET/CT
TP FP FN TN
2 Cetin et al.9 36 16 6 3 11
3 Chauhan et al.10 51 15 1 6 29
4 Nahmias et al.11 49 13 4 4 28
5 Ozer et al.12 144 26 18 20 80
6 Schoder et al.13 36 6 4 3 23
Total 316 76 33 36 171
No. = number of the study, TP = true positive, FP = false posi-
tive FN= false negative, TN= true negative.
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In this group, the patients underwent PET/CT. This group
includes 316 cN0 neck sides which represents the population
of 5 studies. The detection rate (true positive) for PET/CT
was 76 (24%) out of 316 neck sides, false-positive results
were 33(10%) out of 316 neck sides, false-negative results
were 36 (11%) out of 316 neck sides and the true negative
results were 171(54%) out of 316 neck sides (Table 4).
The pooled sensitivity of PET/CT is 68%. There is no sig-
niﬁcant heterogeneity in studies of Group B as the p value of
chi-square test was 0.202 (>0.1) and I2 index was 32.9%
(<50%) (Fig. 1).
The pooled speciﬁcity of PET/CT is 84%. There is signiﬁ-
cant heterogeneity between the speciﬁcity of PET/CT in evalu-
ation of cN0 neck in studies of Group B as the p value of chi-
square test was 0.050 (<0.1) and I2 index was 57.9% (>50%)
(Fig. 2).
The pooled Positive Likelihood Ratio of PET/CT is 3.89.
There is no signiﬁcant heterogeneity in studies of Group B
as The p value of cochran-Q test was 0.131 (>0.1), I2 index
was 43.6% (<50%) and Tau-squared index was 0.136 (<1)
(Fig. 3).The pooled Negative Likelihood Ratio of PET/CT is 0.39.
There is no signiﬁcant heterogeneity in studies of Group B as
the p value of cochran-Q test was 0.281 (>0.1), I2 index was
20.9% (<50%) and Tau-squared index was 0.034 (<1)
(Fig. 4).
The pooled Diagnostic Odds Ratio of PET/CT is 11.96.
There is no signiﬁcant heterogeneity in studies of Group B
as the p value of cochran-Q test was 0.185 (>0.1), I2 index
was 35.4% (<50%) and Tau-squared index was 0.294 (<1)
(Fig. 5).
The prevalence rates of occult metastases in cN0 neck in
patients of groups A, B and total patients were 46%, 35%
and 36% respectively (Table 5).
3.4. Diagnostic accuracy
The sensitivity of DWI for the diagnosis of cN0 neck in
patients with HNSCC was 100%, speciﬁcity (71%), positive
predictive value (75%), negative predictive value (100%) and
accuracy (85%). On the other hand, the sensitivity of PET/
CT for the diagnosis of cN0 neck in patients with HNSCC
was 68%, speciﬁcity (84%), positive predictive value (70%),
negative predictive value (83%) and accuracy (78%) (Table 6).
4. Discussion
The optimal method for managing cN0 neck in SCC of the
head and neck remains controversial. In 1994, Weiss et al.3 rec-
ommended with decision analysis that when the probability of
occult cervical metastases is more than 20%, the neck should
be electively treated. Many staging techniques have been
described for the preoperative staging of the cN0 neck in
HNSCC in order to lower the amount of false-negative necks
to 20% or less. This could lead to a change in treatment for
this group of patients by avoiding SND in patients with a
cN0 neck, thereby reducing postoperative morbidity.
Recently, DWI and PET/CT are new non-invasive diagnos-
tic tools used for the evaluation of cN0 neck in patients with
HNSCC.14,15
There were no studies comparing the role of DWI versus
PET/CT in evaluation of cN0 neck in patients with HNSCC,
so we divided the included studies into 2 groups; then we com-
pared the results of both groups. Havenith et al. adopted this
method.16
The present study revealed generally high quality scores of
the included studies (Table 2); suggesting that most of included
studies presented enough information overall and satisﬁed
most of the requirements established. However most of studies
Figure 1 Forest plot showing the sensitivity of PET/CT in evaluation of cN0 neck in studies of Group B.
Figure 2 Forest plot showing the speciﬁcity of PET/CT in evaluation of cN0 neck in studies of Group.
Figure 3 Forest plot showing the Positive Likelihood Ratio (random effects model) of PET/CT in evaluation of cN0 neck in studies of
Group B.
Figure 4 Forest plot showing the Negative Likelihood Ratio (random effects model) of PET/CT in evaluation of cN0 neck in studies of
Group B.
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Figure 5 Forest plot showing the Diagnostic Odds Ratio (random effects model) of PET/CT in evaluation of cN0 neck in studies of
Group B.
Table 5 The prevalence rates of occult metastases in cN0 neck
in patients with HNSCC of Group A, B and total patients.
Patients Positives by histopathological
examination (true +ve and false ve)
Prevalence
rate (%)
Group A 6 out of 13 patients 46
Group B 112 out of 316 patients 35
Total patients 118 out of 329 patients 36
114 O. Hassan et al.had a suboptimal design in regard to the blinding method
(Item 11) as the interpretation of the histopathological exami-
nation results was done with the knowledge of the imaging
results. Also the time period between histopathological exam-
ination and imaging techniques (DWI and PET/CT) (Item 4)
was not mentioned in 3 articles, so our recommendation to
all the researchers is to pay attention to these points to avoid
bias.
The results of DWI in the present study revealed a high sen-
sitivity (100%) and intermediate speciﬁcity (71%) whereas
Bondt et al.17 reported 92.3% sensitivity and 83.9% speciﬁcity.
This minor discrepancy might be due the inclusion of 3 cN1
among the 17 neck sides in Bondt et al.17 study.
There is no signiﬁcant heterogeneity between the sensitivity,
Positive Likelihood Ratio, Negative Likelihood Ratio and
Diagnostic Odds Ratio in the included studies of Group B
(Figs. 1 and 3–5), while there was signiﬁcant heterogeneity
between the speciﬁcity (Fig. 2) and this was the reason to adapt
a random effect model for data pooling.18
A likelihood ratio greater than 1 indicates that the test
result is associated with the presence of the disease, whereas
a likelihood ratio less than 1 indicates that the test result is
associated with the absence of disease. The further likelihood
ratios are from 1 the stronger the evidence for the presence
or absence of disease. Likelihood ratios above 10 and below
0.1 are considered to provide strong evidence to rule in or rule
out diagnoses respectively in most circumstances.19 In the pres-
ent study, the pooled Positive Likelihood Ratio of PET/CT is
3.89 (Fig. 3). This means that a person with cN0 neck havingTable 6 Diagnostic performance of DWI and PET/CT in evaluatio
Diagnostic tool Sensitivity (%) Speciﬁcity (%) Positive predi
DWI 100 71 75
PET/CT 68 84 70metastatic lymphadenopathy is about 4 times more likely to
have a positive test than a person with cN0 neck who has
not got metastatic lymphadenopathy in cases of HNSCC. On
the other hand, the pooled Negative Likelihood Ratio of
PET/CT is 0.39 (Fig. 4), indicating that the probability of hav-
ing a negative test for individuals with metastatic lymphade-
nopathy in cN0 neck is 0.39 times of that of those without
metastatic lymphadenopathy in cN0 neck of patients with
HNSCC.
The Diagnostic Odds Ratio (DOR) of a test is the ratio of
the odds of positivity in diseased relative to the odds of posi-
tivity in nondiseased. Alternatively, the DOR can be read as
the ratio of the odds of disease in test positives relative to
the odds of disease in test negatives. The value of a DOR
ranges from 0 to inﬁnity, with higher values indicating better
discriminatory test performance. A value of 1 means that a test
does not discriminate between patients with the disorder and
those without it. Values lower than 1 point to improper test
interpretation (more negative tests among the diseased).20 In
the present study, the pooled Diagnostic Odds Ratio of
PET/CT is 11.96 (>1) (Fig. 5). This means that for the
PET/CT the odds for positivity among cN0 neck of subjects
with metastatic lymphadenopathy is nearly 12 times higher
than the odds for positivity among cN0 neck of subjects with-
out metastatic lymphadenopathy.
The pooled sensitivity (68%) and speciﬁcity (84%) of PET/
CT in the present study were slightly discordant with that of
Krabbe et al.21 (64% and 81% respectively). This might be
due to the lower intravenous dose of 18F-FDG (4 MBq/kg
body weight with a maximum of 333 MBq) used in Krabbe
et al.21 than that used in the present study (not lower than
370 MBq of 18F-FDG).
In our study, DW-MRI presents high sensitivity (100%),
Positive predictive value (75%), Negative predictive value
(100%), accuracy (85%) and less speciﬁcity (71%) than PET/
CT (68% sensitivity, 70% Positive predictive value, 83% Neg-
ative predictive value, 78% accuracy and 84% speciﬁcity) in
the preoperative evaluation of clinically N0 neck in cases of
HNSCC (Table 6). These results of DWI indicate the existencen of cN0 neck in both groups.
ctive value (%) Negative predictive value (%) Accuracy (%)
100 85
83 78
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in the management of oncologic patients that could suggest the
utility of DW-MRI in the initial stages of evaluation of cN0
neck of subjects with HNSCC. Also the results of PET/CT
translates to 17% of necks with negative imaging results actu-
ally being metastatic, nearly 1 neck in 5 would have undetected
disease; if untreated, the residual nodal tumor would presum-
ably progress to the detriment of the patient. On the other
hand, 30% of necks identiﬁed as positive would contain no dis-
ease; these patients may have unnecessary treatment. This
leads to the conclusion that a positive test would not help
the clinician in the management of the patient with clinically
N0 disease.
The higher sensitivity of DWI is probably due to the fact
that the majority of the LNs were subcentimetric. This is
because the DW-MRI can detect behavior changes in tissues
before they are visible to the naked eye.22 Several factors
enable the detection of small nodal metastases at DW-
MRI; Use of improved echo-planar imaging technology,
dedicated coils, and dedicated sequence optimization enables
a maximal reduction of echo-planar imaging-related artifacts
at a relatively high spatial resolution,23 on the other hand,
PET has limitations in detecting micro metastasis, related
to spatial resolution of current PET cameras and partial
volume effects.24 The false negative results in PET/CT may
arise due to tumor necrosis, ﬂuorodeoxyglucose is not a
cancer-speciﬁc agent, neutrophils and macrophages during
an ongoing inﬂammatory or granulomatous processes show
increased FDG accumulation and cause false-positive PET
scans for malignancy.12
The prevalence rate of occult metastasis in cN0 neck in
patients with HNSCC was 46% in Group A, 35% in Group
B and 36% in general (Table 5). This percentage is similar to
those reported by other studies which have reported prevalence
rates ranging from 24% to 50%.25,26
The limitations of our study are the presence of only one
study in group 1 and therefore no metaanalysis was done in
this group, also most of the tumors included were T1 and
T2, which could bias the results for the whole cN0 group of
patients.
5. Conclusions
The available evidence suggests that DWI is more sensitive
than PET/CT in the preoperative evaluation of cN0 neck in
patients with HNSCC. This indicates the existence of few
false-negative results, an important feature in the management
of oncologic patients that could suggest its utility in the initial
stages of the management process. PET/CT exam has low sen-
sitivity and a positive test would not help the clinician in the
management of the patient with clinically N0 disease and
therefore, it should not be routinely used in neck nodal status
work-ups.
6. Recommendations
 Multi-center prospective randomized double blind con-
trolled trials comprising larger patient cohorts comparing
between the roles of DW-MRI versus PET/CT in evalua-
tion of cN0 neck in patients with HNSCC are required. Values of ADC and SUV of ﬂuorodeoxyglucose must be
deﬁned in these trials.
 Researchers should pay attention to fulﬁll QUADAS items
specially the blinding method and the time period between
the imaging techniques and histopathological examination.
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